Dr Agarwals Healthcare, a eye care based company, today made its debut on the Indian stock market after opening its IPO for subscription from January 29 to January 31. A mainboard issue, the shares of the company was listed on both the Indian headline indices – BSE and NSE.
On the BSE, the shares opened at Rs 396.90 per share, a down 1.27% that the issue price of Rs 398. Meanwhile, on the NSE, the shares began trading at Rs 402 per share.
Dr Agarwals Healthcare IPO: GMP
Ahead of its official listing, the GMP for Dr Agarwals Healthcare IPO has been seen trading below the issue price of Rs 398. The GMP was seen to be lower than expected, indicating a lukewarm reception.
Dr Agarwals Healthcare IPO: Subscription status
The IPO attracted a modest level of interest, with a final subscription of 1.49 times on January 31, the closing day of the issue.
Also ReadDr Agarwal’s Healthcare allotment today: How to check allotment status online on BSE, NSE, KFin Technologies
Breaking it down further to category wise, the retail category saw a relatively low subscription of 0.42 times, while QIBs portion was subscribed 4.41 times. Furthermore, the NIIs were less active, subscribing only 0.39 times.
Dr Agarwals Healthcare IPO: Key highlights of the issue
he IPO was available for subscription from January 29 to January 31, with a price band set between the range of 382 to 402 per share.
The allotment for the IPO was finalised on February 3. Kotak Mahindra Capital Company, Morgan Stanley India, Jefferies India, and Motilal Oswal Investment Advisors were the book running lead managers of this issue and Kfi Technologies acted as the registrar.
The company raised Rs 875.51 crore from anchor investors ahead of the public issue, with the anchor bid date set as January 28.
Founded in 2010, Dr Agarwals Healthcare is engaged in the eye care sector and offers a wide range of services, including cataract and refractive surgeries, routine consultations, diagnostics, and non-surgical treatments.
» Read More
